Report
Lourdeena Kudaliyanage
EUR 4.56 For Business Accounts Only

JKSB Full Year Highlights_Commercial Bank of Ceylon PLC (COMB)_CY16

COMB reported a healthy 22% YoY increase in full year earnings for CY16, driven mainly by 1) an 8% YoY increase in net interest income, supported by 22% loan book growth (amid a slight contraction in NIM); a 2) a reversal of Rs. 1.9bn on collective impairment charges; and 3) a lower effective tax rate for the year. NIM contraction (-0.2ppt YoY to 3.47%) for the year, stems largely from a lower CASA ratio (-8ppt YoY to 42%) which reflects a widening interest rate differential between savings and fixed deposits amid rising funding costs across the sector. Net loan book growth for the year (+22% YoY) was supported by healthy growth in 1) term loans - short term +65% YoY and long term +23% YoY; 2) overdrafts (+24% YoY); and 3) housing loans (+17% YoY). QoQ loan book growth picked up in the Dec quarter (+7% QoQ in 4QCY16 vs. +4% QoQ in 3QCY16 and +3% QoQ in 2QCY16).

We expect CY17 to be a more difficult year for the banking sector as a whole, with credit growth expected to slow down (COMB’s credit growth should be ~2ppt higher than industry growth in CY17) amid a projected drop in demand in the leasing and housing segments, while operators with exposure to agriculture-related micro finance/SME lending could see a negative impact due to the prevailing drought (COMB is not exposed to this segment). We project full year earnings of Rs. 15.9bn for COMB for CY17, translating to an EPS of Rs. 17.78 (+9% YoY). While a repricing of balance sheet assets should somewhat alleviate pressure on NIMs in CY17, we expect funding costs to continue to rise across the sector given strong competition amid smaller sized banks for 3m and 6m deposits. At its current price of Rs. 143.00, COMB trades at a CY17E P/E of 8.0x and a P/BV of 1.6x , at a premium to our banking & finance coverage universe P/E.

Underlying
Commercial Bank of Ceylon

Provider
John Keells Stock Brokers
John Keells Stock Brokers

​•JKSB is one of 15 founding members of the Colombo Stock Exchange with roots in share trading dating back to 1896, and is a subsidiary of John Keells Holdings PLC (JKH), the largest listed entity on the Colombo Stock Exchange with a market capitalization of US$ 1.3bn.

•JKSB’s core client base is Foreign Institutional Investors, Local Institutions and HNWI’s

•JKSB has a co-branded Research tie up with CIMB and a Research Referral agreement with Credit Suisse, along with trade execution relationships with several other global and regional securities firms.

•JKSB’s trade execution partners include Credit Suisse, CIMB, Merrill Lynch, Exotix, Daiwa, Convergex, Deutsche Asia Securities and Morgan Stanley

•JKSB is a research contributor to Bloomberg on ‘KEEL’ , Thomson First Call, Reuters Knowledge and FactSet

•The JKSB Research Universe covers 72 stocks across 15 sectors, with most Research efforts focused on approximately 45 of the more liquid counters.

•The JKSB Universe constitutes 67% of total market cap and approximately 80% of turnover at the CSE.

Analysts
Lourdeena Kudaliyanage

Other Reports on these Companies
Other Reports from John Keells Stock Brokers

ResearchPool Subscriptions

Get the most out of your insights

Get in touch